153 related articles for article (PubMed ID: 34976797)
1. MicroRNA-20a Suppresses Tumor Proliferation and Metastasis in Hepatocellular Carcinoma by Directly Targeting EZH1.
Zhang Q; Deng X; Tang X; You Y; Mei M; Liu D; Gui L; Cai Y; Xin X; He X; Huang J
Front Oncol; 2021; 11():737986. PubMed ID: 34976797
[TBL] [Abstract][Full Text] [Related]
2. EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma.
Kusakabe Y; Chiba T; Oshima M; Koide S; Rizq O; Aoyama K; Ao J; Kaneko T; Kanzaki H; Kanayama K; Maeda T; Saito T; Nakagawa R; Kobayashi K; Kiyono S; Nakamura M; Ogasawara S; Suzuki E; Nakamoto S; Yasui S; Mikata R; Muroyama R; Kanda T; Maruyama H; Kato J; Mimura N; Ma A; Jin J; Zen Y; Otsuka M; Kaneda A; Iwama A; Kato N
Sci Rep; 2021 Nov; 11(1):21396. PubMed ID: 34725436
[TBL] [Abstract][Full Text] [Related]
3. miR-17-5p and miR-20a-5p suppress postoperative metastasis of hepatocellular carcinoma via blocking HGF/ERBB3-NF-κB positive feedback loop.
Liu DL; Lu LL; Dong LL; Liu Y; Bian XY; Lian BF; Xie L; Wen D; Gao DM; Ke AW; Fan J; Wu WZ
Theranostics; 2020; 10(8):3668-3683. PubMed ID: 32206115
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
5. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
Huang B; Huang M; Li Q
Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
[TBL] [Abstract][Full Text] [Related]
7. Targeting of miR-20a against CFLAR to potentiate TRAIL-induced apoptotic sensitivity in HepG2 cells.
Wang Y; Zhao YR; Zhang AY; Ma J; Wang ZZ; Zhang X
Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2087-2097. PubMed ID: 28537677
[TBL] [Abstract][Full Text] [Related]
8. Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition.
Rizq O; Mimura N; Oshima M; Saraya A; Koide S; Kato Y; Aoyama K; Nakajima-Takagi Y; Wang C; Chiba T; Ma A; Jin J; Iseki T; Nakaseko C; Iwama A
Clin Cancer Res; 2017 Aug; 23(16):4817-4830. PubMed ID: 28490465
[No Abstract] [Full Text] [Related]
9. [LncRNA HULC promots HCC growth by downregulating miR-29].
Zhu LR; Feng JL; Liu XJ; Wang JM
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):659-666. PubMed ID: 31550855
[No Abstract] [Full Text] [Related]
10. Restoration of miR-20a expression suppresses cell proliferation, migration, and invasion in HepG2 cells.
Chen GS; Zhou N; Li JQ; Li T; Zhang ZQ; Si ZZ
Onco Targets Ther; 2016; 9():3067-76. PubMed ID: 27313460
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma.
Ding W; Tan H; Li X; Zhang Y; Fang F; Tian Y; Li J; Pan X
Cancer Biomark; 2018; 22(3):427-434. PubMed ID: 29758928
[TBL] [Abstract][Full Text] [Related]
12. LncRNA CRNDE promotes hepatocellular carcinoma cell proliferation, invasion, and migration through regulating miR-203/ BCAT1 axis.
Ji D; Jiang C; Zhang L; Liang N; Jiang T; Yang B; Liang H
J Cell Physiol; 2019 May; 234(5):6548-6560. PubMed ID: 30230527
[TBL] [Abstract][Full Text] [Related]
13. Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma.
Cheng B; Ding F; Huang CY; Xiao H; Fei FY; Li J
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):137-145. PubMed ID: 30657555
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis.
Wang H; Ke J; Guo Q; Barnabo Nampoukime KP; Yang P; Ma K
J Cell Mol Med; 2018 Dec; 22(12):5862-5876. PubMed ID: 30246921
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
Ma J; Li T; Han X; Yuan H
J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
[TBL] [Abstract][Full Text] [Related]
16. Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma.
Fan MQ; Huang CB; Gu Y; Xiao Y; Sheng JX; Zhong L
J Exp Clin Cancer Res; 2013 Apr; 32(1):21. PubMed ID: 23594563
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL
FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121
[TBL] [Abstract][Full Text] [Related]
18. TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a.
Liu W; Feng Q; Liao W; Li E; Wu L
J Cancer; 2021; 12(22):6905-6920. PubMed ID: 34659578
[No Abstract] [Full Text] [Related]
19. MicroRNA-147 suppresses human hepatocellular carcinoma proliferation migration and chemosensitivity by inhibiting HOXC6.
Sui CJ; Xu F; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
Am J Cancer Res; 2016; 6(12):2787-2798. PubMed ID: 28042500
[TBL] [Abstract][Full Text] [Related]
20. LINC00339 regulates ROCK1 by miR-152 to promote cell proliferation and migration in hepatocellular carcinoma.
Chen K; Zhang L
J Cell Biochem; 2019 Sep; 120(9):14431-14443. PubMed ID: 31081143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]